Organogenesis Holdings Inc. to Report First Quarter of Fiscal Year 2021 Financial Results on May 10, 2021

Rhea-AI Summary

Organogenesis Holdings Inc. (Nasdaq: ORGO) will announce its first quarter fiscal year 2021 financial results after market close on May 10. A conference call is scheduled for the same day at 5:00 p.m. ET to discuss the results and provide corporate updates. Interested participants can join by dialing 866-795-3142, with international callers using 409-937-8908, and using access code 9199306. A live webcast will also be available on their investor relations website, with a replay accessible for two weeks following the call.

Positive

• Scheduled reporting of financial results may indicate transparency and investor engagement.

Negative

• None.

CANTON, Mass., April 12, 2021 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, today announced that first quarter of fiscal year 2021 financial results will be reported after the market closes on Monday, May 10.

Management will host a conference call at 5:00 p.m. Eastern Time on May 10 to discuss the results of the quarter, and provide a corporate update with a question and answer session. Those who would like to participate may dial 866-795-3142 (409-937-8908 for international callers) and provide access code 9199306. A live webcast of the call will also be provided on the investor relations section of the Company's website at investors.organogenesis.com.

For those unable to participate, a replay of the call will be available for two weeks at 855-859-2056 (404-537-3406 for international callers); access code 9199306. The webcast will be archived at investors.organogenesis.com.

About Organogenesis Holdings Inc.
Organogenesis Holdings Inc. is a leading regenerative medicine company offering a portfolio of bioactive and acellular biomaterials products in advanced wound care and surgical biologics, including orthopedics and spine. Organogenesis’s comprehensive portfolio is designed to treat a variety of patients with repair and regenerative needs. For more information, visit www.organogenesis.com.

FAQ

When will Organogenesis Holdings report its Q1 2021 financial results?

Organogenesis Holdings will report its Q1 2021 financial results after market close on May 10, 2021.

What time is the conference call for ORGO's Q1 2021 results?

The conference call for ORGO's Q1 2021 results is scheduled for 5:00 p.m. Eastern Time on May 10, 2021.

How can I join the conference call for Organogenesis Holdings?

You can join the conference call by dialing 866-795-3142 for U.S. callers or 409-937-8908 for international callers, using access code 9199306.

Will there be a replay available for the conference call?

Yes, a replay of the conference call will be available for two weeks by calling 855-859-2056 for U.S. callers and 404-537-3406 for international callers, using access code 9199306.